The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
GLUCOCORTICOID AND MINERALOCORTICOID RECEPTORS: Biology and Clinical Relevance
Abstract
Mineralocorticoid and glucocorticoid receptors act as homodimers via canonical pentadecamer hormone response elements to regulate transcription. Glucocorticoid, but as yet not mineralocorticoid, receptors have been shown also to modulate AP-1- and NF kappa B-induced transcription by direct protein-protein interactions. The role of 11 beta-hydroxysteroid dehydrogenase in conferring aldosterone specificity on epithelial mineralocorticoid receptors has been proven by the demonstration of sequence mutations in all cases of apparent mineralocorticoid excess examined to date. The autosomal form of aldosterone resistance (pseudohypoaldosteronism) has been shown to reflect loss-of-function mutations in epithelial sodium channel subunit sequence. (Patho)physiological roles for aldosterone and glucocorticoid membrane receptors, and for the recently described nuclear receptors for 11-ketosteroids in 11 beta-hydroxysteroid dehydro-genase-protected epithelia, remain to be established.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Once bound to their hormone ligand, MRs and GRs act as transcription factors by migrating to the nucleus and binding to hormone response elements often found in gene promoters (Funder, 1997).”
From The Epigenetics of Anxiety Pathophysiology: A DNA Methylation and Histone Modification Focused Review (2023) · cites this paper as Funder, 1997
In the citing paper
“These corticosteroids are commonly known as “stress hormones,” and are capable of binding to two intracellular receptors: mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs).”
From The Epigenetics of Anxiety Pathophysiology: A DNA Methylation and Histone Modification Focused Review (2023) · cites this paper as Funder, 1997
Citations
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Chang, S. S., Grunder, S., Hanukoglu, A., Rösler, A., Mathew, P. M., Hanukoglu, I., Schild, L., Lu, Y., Shimkets, R. A., Nelson-Williams, C., et al. (1996) · Nature Genetics · doi:10.1038/ng0396-248 · Cited by 808
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117943 · Cited by 642
A corticosteroid receptor in neuronal membranes
Orchinik, M., Murray, T. F., & Moore, F. L. (1991) · Science · doi:10.1126/science.2063198 · Cited by 523
Hurley, D. M., Accili, D., Stratakis, C. A., Karl, M., Vamvakopoulos, N., Rorer, E., Constantine, K., Taylor, S. I., & Chrousos, G. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115046 · Cited by 370
Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies
Myles, K., & Funder, J. W. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.4.e601 · Cited by 102
Self-citationClinical aspects of glucocorticoid sensitivity
Lamberts, S. W. J., Huizenga, A. T. M., de Lange, P., de Jong, F. H., & Koper, J. W. (1996) · Steroids · doi:10.1016/0039-128x(96)00005-0 · Cited by 99
Research works printed but not linked: 47
- 10.1038/318635a0 · DOI
- 10.1126/science.3037703 · DOI · Paper page
- 10.1073/pnas.80.19.6056 · DOI
- Myles K, 1996, Am. J. Physiol., 33, E601
- 10.1126/science.8197458 · DOI
- 10.1038/377451a0 · DOI
- 10.1038/377397a0 · DOI
- 10.1016/0896-6273(94)90431-6 · DOI
- 10.1073/pnas.92.26.12480 · DOI
- 10.1210/me.7.10.1244 · DOI
- 10.1016/0960-0760(94)90190-2 · DOI
- 10.1126/science.8382376 · DOI
- 10.1210/en.135.3.834 · DOI
- 10.1152/ajpcell.1996.271.1.C423 · DOI
- 10.1073/pnas.88.19.8283 · DOI
- 10.1210/me.7.4.597 · DOI
- 10.1093/chemse/20.2.251 · DOI
- 10.1126/science.270.5234.283 · DOI
- 10.1126/science.270.5234.286 · DOI · Paper page
- 10.1073/pnas.91.2.752 · DOI
- 10.1002/j.1460-2075.1995.tb07021.x · DOI
- 10.1002/j.1460-2075.1994.tb06726.x · DOI
- 10.1210/endo.137.10.8828470 · DOI
- Myles K, 1994, Am. J. Physiol., 267, E268
- 10.1016/0303-7207(94)90176-7 · DOI · Paper page
- 10.1210/jc.80.7.2263 · DOI
- 10.1038/ng0895-394 · DOI · Paper page
- 10.1210/jc.80.11.3145 · DOI
- Naray-Fejes-Toth A, 1990, Am. J. Physiol., 259, F672
- 10.1096/fasebj.4.14.2172062 · DOI
- 10.1152/ajpendo.1990.258.4.E649 · DOI
- 10.1152/ajpendo.1992.262.1.E96 · DOI
- Gomez-Sanchez EP, 1990, Am. J. Physiol., 258, E482
- Young M, 1995, Am. J. Physiol., 269, E657
- Brilla CG, 1992, J. Lab. Clin. Med., 120, 893
- Young M, 1996, Am. J. Physiol.
- 10.1172/JCI116410 · DOI
- 10.1016/0039-128X(96)00017-7 · DOI
- 10.1136/adc.33.169.252 · DOI
- 10.1056/NEJM198511073131902 · DOI
- 10.1210/jc.79.1.32 · DOI
- 10.1210/jc.79.1.27 · DOI
- 10.1210/jc.79.4.1019 · DOI
- 10.1210/jc.80.11.3341 · DOI
- 10.1101/gad.9.13.1608 · DOI · Paper page
- 10.1161/01.RES.76.6.973 · DOI
- 10.1210/endo.137.8.8754750 · DOI
Cited by
Sorted by citations
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Coutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
“Type 2 11 -HSD (11 -HSD2) inactivates glucocorticoids in vivo, thus protecting the otherwise non-selective MR from occupation by glucocorticoids (Funder, 1997; Seckl, 2000).”
Molecular and cellular endocrinology
Gianaroli, L., Ferraretti, A., Canale, D., Foresta, C., & Magli, M. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00232-x · Cited by 1,741
“* p < 0.05 and ** p < 0.01, when compared with the non-insulinic group. and cardiovascular diseases (Shimomura et al., 1999).”
InfluentialThe stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393
Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
Gellersen, B., & Brosens, J. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1045 · Cited by 1,176
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
“At the cellular level, the myriad effects of corticosteroids are largely a consequence of transcriptional actions mediated via binding to two types of intracellular receptor: the highaffinity mineralocorticoid receptor (MR) and the lower affinity glucocorticoid receptor (GR) (208, 452).”
BackgroundVincenti, M. P., & Brinckerhoff, C. E. (2002) · Arthritis Research & Therapy · doi:10.1186/ar401 · Cited by 796
“ments present in the promoters of many genes [52].”
BackgroundThe effects of aging in the hippocampus and cognitive decline
Bettio, L. E. B., Rajendran, L., & Gil‐Mohapel, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.030 · Cited by 700
“Glucocorticoids (cortisol in humans and corticosterone in rodents) act through two types of nuclear receptors: the mineralocorticoid receptor (MR), a high-affinity receptor that is activated by basal concentrations of these hormones, and the glucocorticoid receptor (GR), a low-affinity receptor that is activated in th…”
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Féraille, E., & Doucet, A. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.345 · Cited by 490
Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory
Yuen, E. Y., Liu, W., Karatsoreos, I. N., Feng, J., McEwen, B. S., & Yan, Z. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906791106 · Cited by 481
“Corticosterone Acts through Glucocorticoid or Mineralocorticoid Receptors (23).”
BackgroundMechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory
Yuen, E. Y., Liu, W., Karatsoreos, I. N., Ren, Y., Feng, J., McEwen, B. S., & Yan, Z. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.50 · Cited by 324
Multiple aspects of mineralocorticoid selectivity
Farman, N., & Rafestin-Oblin, M.-E. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f181 · Cited by 268
HPA axis responsiveness to stress: implications for healthy aging
Aguilera, G. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.023 · Cited by 250
“It should be noted that glucocorticoids bind with even higher affinity to the mineralocorticoid receptor, and that both receptors bind to the same responsive element in the DNA (Funder, 1997).”
BackgroundKauppi, B., Jakob, C., Färnegårdh, M., Yang, J., Ahola, H., Alarcon, M., Calles, K., Engström, O., Harlan, J., Muchmore, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212711200 · Cited by 250
Gray, J. D., Milner, T. A., & McEwen, B. S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.034 · Cited by 250
“GCs can bind both GRs and mineralocorticoid receptors (MR), which are distinguished by their downstream effects, but both serve primarily as transcription factors after activation (Funder, 1997).”
BackgroundXu, L., Hölscher, C., Anwyl, R., & Rowan, M. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3204 · Cited by 234
11β-Hydroxysteroid dehydrogenases and the brain: From zero to hero, a decade of progress
Wyrwoll, C. S., Holmes, M. C., & Seckl, J. R. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.12.001 · Cited by 244
“Once inside the cell, corticosteroids bind to the two main types of intracytoplasmic receptors; GR and MR [71,165,220].”
What pharmacologists can learn from recent advances in estrogen signalling.
Gustafsson, J. (2003) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00229-3 · Cited by 243
Hippocampal gene expression changes underlying stress sensitization and recovery
Gray, J. D., Rubin, T. G., Hunter, R. G., & McEwen, B. S. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.175 · Cited by 242
“Finally, the glucocorticoid receptor (GR) gene (Nr3c1), an essential transcription factor mediating stress-induced changes in the hippocampus (19), was not altered by any of the acute stress conditions, but trended toward a decrease after CRS on the microarrays.”
BackgroundThe clinical use of corticosteroids in pregnancy
Kemp, M. W., Newnham, J. P., Challis, J. R. G., Jobe, A., & Stock, S. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv047 · Cited by 224
“At physiological concentrations, endogenous corticosteroids bind to the MR with 10 times greateraffinityforMRthanGR(Funder,1997).”
BackgroundCronstein, B. N., Montesinos, M. C., & Weissmann, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6377 · Cited by 183
Chapter 1.1 Anatomy and function of extrahypothalamic vasopressin systems in the brain
Vries, G. J. D., & MILLER, M. A. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61558-7 · Cited by 189
Li, Y., Suino, K., Daugherty, J., & Xu, H. (2005) · Molecules and Cells · doi:10.1016/j.molcel.2005.06.026 · Cited by 188
“MR is a member of the classic steroid hormone receptors that include GR, androgen receptor (AR), progesterone receptor (PR), and estrogen receptor (ER) (Funder, 1997).”
BackgroundMaternal hormonal milieu influence on fetal brain development
Miranda, A., & Sousa, N. (2018) · Brain and Behavior · doi:10.1002/brb3.920 · Cited by 199
“MR have a 10- fold higher affinity for circulating endogenous glucocorticoids than GR and are therefore responsible for the maintenance of basal HPA activity, while GR signal mainly during acute stress (Funder, 1997; Reul & de Kloet, 1985).”
BackgroundThe serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action.
Bhargava, A., Fullerton, M., Myles, K., Purdy, T. M., Funder, J., Pearce, D., & Cole, T. J. (2001) · Endocrinology · doi:10.1210/endo.142.4.8095 · Cited by 174
Role of 11β-Hydroxysteroid Dehydrogenase in Nongenomic Aldosterone Effects in Human Arteries
Alzamora, R., Michea, L., & Marusic, E. T. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1099 · Cited by 170
Glucocorticoids and Type 2 Diabetes: From Physiology to Pathology
Di Dalmazi, G., Pagotto, U., Pasquali, R., & Vicennati, V. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/525093 · Cited by 168
New ideas about aldosterone signaling in epithelia
Stockand, J. D. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00320.2001 · Cited by 158
“The interested reader has many excellent contemporary review articles available for a discussion of the effects of aldosterone at the systemic, tissue, cellular, and molecular levels and for a history of important findings in this field (51, 52, 58, 70, 176, 177).”
Burton, P. J., & Waddell, B. J. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.2.234 · Cited by 155
Potential significance of physiological and pharmacological glucocorticoids in early pregnancy
Michael, A. E., & Papageorghiou, A. T. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn021 · Cited by 173
Hypothalamic‐Pituitary‐Adrenal (HPA) Axis and Aging
Gupta, D., & Morley, J. E. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130049 · Cited by 210
“In the brain, especially in the HC, 11 β -hydroxysteroid dehydrogenase type 1 (11 β -HSD-1) which regenerates active glucocorticoids, is widely expressed but the type 2 isoenzyme of this enzyme, which rapidly inactivates glucocorticoids is undetectable (47,76,113).”
Savory, J. G. A., Préfontaine, G. G., Lamprecht, C., Liao, M., Walther, R. F., Lefebvre, Y. A., & Haché, R. J. G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.781-793.2001 · Cited by 163
“The effects of corticosteroids are determined through asymmetric distribution of the mineralocorticoid and glucocorticoid nuclear hormone receptors (MR and GR) and the protective effects of 11b-hydroxysteroid dehydrogenase, which selectively metabolizes glucocorticoids (2, 20, 31).”
Background50th Anniversary of Aldosterone
Williams, J. S., & Williams, G. H. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030490 · Cited by 150
Sato, A., & Saruta, T. (2001) · Journal of International Medical Research · doi:10.1177/147323000102900103 · Cited by 148
Caprio, M., Antelmi, A., Chetrite, G., Muscat, A., Mammi, C., Marzolla, V., Fabbri, A., Zennaro, M., & Fève, B. (2010) · Endocrinology · doi:10.1210/en.2010-0674 · Cited by 139
Early aldosterone action: toward filling the gap between transcription and transport
Verrey, F. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.3.f319 · Cited by 128
Mick, V. E., Itani, O. A., Loftus, R., Husted, R., Schmidt, T. J., & Thomas, C. P. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.4.0620 · Cited by 133
Rog‐Zielinska, E. A., Craig, M.-A., Manning, J. R., Richardson, R. V., Gowans, G. J., Dunbar, D. R., Gharbi, K., Kenyon, C. J., Holmes, M. C., Hardie, D. G., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.181 · Cited by 130
“We therefore compared the effect of corticosterone with that of dexamethasone, which poorly activates MR.(16) Dexamethasone induced all four mRNAs in a dose-dependent manner over 24 h (Figures 3a–d).”
BackgroundResultRole of the Glucocorticoid Receptor for Regulation of Hypoxia-dependent Gene Expression
Kodama, T., Shimizu, N., Yoshikawa, N., Makino, Y., Ouchida, R., Okamoto, K., Hisada, T., Nakamura, H., Morimoto, C., & Tanaka, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302581200 · Cited by 116
Attur, M. G., Patel, R., Thakker, G. D., Vyas, P., Levartovsky, D., Patel, P., Naqvi, S., Raza, R., Patel, K., Abramson, D., et al. (2000) · Inflammation Research · doi:10.1007/pl00000199 · Cited by 122
“It is also know that glucocorticoids, widely used immunosuppressive and potent anti-inflammatory drug, inhibits induction of iNOS and COX-2 expression in a variety of cell lines in response to various stimuli by inhibiting NF-AT, NFkB and CBP (CREB-binding protein) activation [60, 61].”
BackgroundFrom molecule to market: steroid hormones and financial risk-taking
Coates, J., Gurnell, M., & Sarnyai, Z. (2009) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2009.0193 · Cited by 119
“Hormone-bound receptor then trafficks into the nucleus where it seeks out, and interacts with, specific regions of the DNA to control the rate at which target genes are ‘switched on’ (activation) or ‘switched off ’ (repression) (figure 1) (Tsai & O’Malley 1994; Funder 1997).”
Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes
Kino, T., & Chrousos, G. P. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1690437 · Cited by 109
“The MR of the distal convoluted tubule and possibly other mineralocorticoid target tissues are protected from the actions of cortisol by expression of 11 -hydroxysteroid dehydrogenase type 2, which converts cortisol into the inactive cortisone (Funder 1997).”
BackgroundPutative role of neuronal 5-lipoxygenase in an aging brain
Manev, H., Uz, T., Sugaya, K., & Qu, T. (2000) · The FASEB Journal · doi:10.1096/fj.14.10.1464 · Cited by 113
“Although there are no data pointing to a direct action of glucocorticoid receptors on the 5-LOX gene promoter, the possibility of such an interaction can be assumed based on the presence of the ‘AGAACA’ sequence in the response element of this promoter (bp 21804 to 21809) (40), a sequence indicative of the partial glu…”
BackgroundSamarasinghe, R. A., Di Maio, R., Volonte, D., Galbiati, F., Lewis, M., Romero, G., & DeFranco, D. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102821108 · Cited by 120
Role of glucocorticoid in developmental programming: Evidence from zebrafish
Nesan, D., & Vijayan, M. M. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.10.006 · Cited by 136
Stress and tinnitus—from bedside to bench and back
Mazurek, B., Haupt, H., Olze, H., & Szczepek, A. J. (2012) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2012.00047 · Cited by 124
“The genomic reactions occur due to the fact that both GRs and mineralcorticoid receptors are cytoplasmic, ligand-activated transcription factors (Funder, 1997).”
BackgroundMineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.
Trune, D., Kempton, J., & Gross, N. D. (2006) · Hearing Research · doi:10.1016/j.heares.2005.10.006 · Cited by 106
Jones, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01008 · Cited by 135
Cole, T. J., Myles, K., Purton, J. F., Brereton, P., Solomon, N., Godfrey, D., & Funder, J. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00407-x · Cited by 105
Giordano, R., Pellegrino, M., Picu, A., Bonelli, L., Balbo, M. L., Berardelli, R., Lanfranco, F., & Ghigo, E. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.09 · Cited by 98
“Glucocorticoid actions are mediated by two receptor types: type 1, or mineralocorticoid receptor (MR), and type 2, or glucocorticoid receptor (GR), both of which have been cloned in humans[3,4,28].”
BackgroundInfluentialTumor suppressor protein (p)53, is a regulator of NF-κB repression by the glucocorticoid receptor
Murphy, S. H., Suzuki, K., Downes, M., Welch, G. L., De Jesus, P., Miraglia, L. J., Orth, A. P., Chanda, S. K., Evans, R. M., & Verma, I. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114420108 · Cited by 93
Goncharova, N. D. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00026 · Cited by 102
“GRs are distributed throughout the brain, but mostly in hypothalamic neurons and corticotrophs (Jacobson and Sapolsky, 1991; Funder, 1997), whereas MRs are present in the hypothalamus and in the greatest numbers in the hippocampus (Ratka et al.”
BackgroundAldosterone-Induced Organ Damage: Plasma Aldosterone Level and Inappropriate Salt Status
Sato, A., & Saruta, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.303 · Cited by 87
Faught, E., Aluru, N., & Vijayan, M. M. (2016) · Fish physiology · doi:10.1016/b978-0-12-802728-8.00004-7 · Cited by 118
Regulation of vertebrate corticotropin-releasing factor genes
Yao, M., & Denver, R. J. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.01.046 · Cited by 86
“Two types of intracellular GC receptors are expressed in the brain: the high aYnity type I receptor (also called the mineralocorticoid receptor; MR), and the lower aYnity type II receptor (also called the glucocorticoid receptor; GR) (see Funder, 1997, for review).”
Paul, S., Jeon, W. K., Bizon, J. L., & Han, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00043 · Cited by 106
“After GR binding, these activated receptors are translocated to the nucleus where they bind to the glucocorticoid responsive elements (GRE) and affect the transcriptional activity of target genes (Funder, 1997).”
BackgroundWork-related stress in an emergency medical dispatch center
Weibel, L., Gabrion, I., Aussedat, M., & Kreutz, G. (2003) · Annals of Emergency Medicine · doi:10.1067/mem.2003.109 · Cited by 75
Malcher‐Lopes, R., Franco, A. J., & Tasker, J. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.033 · Cited by 92
Glucocorticoids and foetal heart maturation; implications for prematurity and foetal programming
Rog‐Zielinska, E. A., Richardson, R. V., Denvir, M. A., & Chapman, K. E. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0204 · Cited by 84
“Both exert effects predominantly through binding to DNA, though rapid non-genomic signalling has also been reported for both (reviewed Funder (1997), Buckingham (2006), Dooley et al. (2012) and from Bioscientifica.com at 11/14/2019 09:30:57PM via free access Jo u rn a l o f M o le cu la r E n d o…”
BackgroundBreuner, C. W., & Orchinik, M. (2009) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2009.01.027 · Cited by 70
Liu, W., Yuen, E. Y., & Yan, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050229 · Cited by 78
Hirata, A., Maeda, N., Nakatsuji, H., Hiuge-Shimizu, A., Okada, T., Funahashi, T., & Shimomura, I. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.139 · Cited by 88
Préfontaine, G. G., Walther, R. F., Giffin, W., Lemieux, M. E., Pope, L., & Haché, R. J. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.26713 · Cited by 80
Non-genomic effect of glucocorticoids on cardiovascular system
Lee, S. R., Kim, H. K., Youm, J. B., Dizon, L. A., Song, I. S., Jeong, S. H., Seo, D. Y., Ko, K. S., Rhee, B. D., Kim, N., et al. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1155-2 · Cited by 78
“Together with GR, MR is found in heart tissue [32–34].”
Haque, M., Kaminsky, L., Abdulqadir, R. F., Engers, J., Kovtunov, E., Rawat, M., Al-Sadi, R., & Ma, T. Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1348010 · Cited by 71
“The IKK catalytic subunits enzymatically catalyze the phosphorylation, ubiquitination, and degradation of I k B-a protein and the concomitant NF-k B p50/ p65 activation (124, 125).”
BackgroundGreen, M. R., & McCormick, C. M. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.02.004 · Cited by 84
Marzolla, V., Armani, A., Feraco, A., Martino, M. U. D., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.001 · Cited by 75
“They exert their function in different target tissues by binding two intracellular receptors: the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR) [2], and are able to regulate multiple metabolic pathways, including glycolysis/gluconeogenesis, fatty acids and cholesterol metabolism [3].”
BackgroundLattin, C., Waldron-Francis, K., Richardson, J. W., de Bruijn, R., Bauer, C. M., Breuner, C., & Romero, L. M. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.08.007 · Cited by 69
“Given MR’s importance in regulating sodium balance (via ALDO binding) in mammals [22], we expected to see greater MR capacity than GR capacity in house sparrow.”
BackgroundMineralocorticoid selectivity: Molecular and cellular aspects
Farman, N., & Bocchi, B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00976.x · Cited by 63
Uz, T., Dwivedi, Y., Savani, P. D., Impagnatiello, F., Pandey, G. N., & Manev, H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730693.x · Cited by 61
Mineralocorticoids in the Heart and Vasculature: New Insights for Old Hormones
Lother, A., Moser, M., Bode, C., Feldman, R. D., & Hein, L. (2014) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124302 · Cited by 65
Giordano, R., Bo, M., Pellegrino, M., Vezzari, M., Baldi, M., Picu, A., Balbo, M. L., Bonelli, L., Migliaretti, G., Ghigo, E., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0105 · Cited by 61
Regulation of S100A8 by Glucocorticoids1
Hsu, K. J., Passey, R., Endoh, Y., Rahimi, F., Youssef, P., Yen, T., & Geczy, C. (2005) · Journal of Immunology · doi:10.4049/jimmunol.174.4.2318 · Cited by 65
Role of mineralocorticoid receptors on the hypothalamus–pituitary–adrenal axis in humans
Berardelli, R., Karamouzis, I., D’Angelo, V., Zichi, C., Fussotto, B., Giordano, R., Ghigo, E., & Arvat, E. (2012) · Endocrine · doi:10.1007/s12020-012-9750-8 · Cited by 62
Lai, L., Chen, J., Hao, C.-M., Lin, S.-T., & Gu, Y. (2006) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2006.07.057 · Cited by 64
Glucose metabolism in patients with subclinical Cushing’s syndrome
Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., D’Angelo, V., Marinazzo, E., Picu, A., Ghigo, E., & Arvat, E. (2012) · Endocrine · doi:10.1007/s12020-012-9628-9 · Cited by 64
Kuroda, K., Venkatakrishnan, R., Salker, M. S., Lucas, E. S., Shaheen, F., Kuroda, M., Blanks, A., Christian, M., Quenby, S., & Brosens, J. J. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1247 · Cited by 63
Modulation of synaptic plasticity by exercise
Bettio, L. E. B., Thacker, J. S., Hutton, C. P., & Christie, B. R. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.07.002 · Cited by 87
Nuclear Receptors in Leydig Cell Gene Expression and Function1
Martin, L. J., & Tremblay, J. J. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.110.083824 · Cited by 62
“2A) called the glucocorticoid response element (GRE) found in the promoter region of target genes, resulting in either transcriptional activation or repression (reviewed in Funder [94]).”
BackgroundAldosterone and the heart: towards a physiological function?
Delcayre, C., & Silvestre, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00088-7 · Cited by 62
The Bacterial and Viral Agents of BRDC: Immune Evasion and Vaccine Developments
Bell, R. L., Turkington, H. L., & Cosby, S. L. (2021) · Vaccines · doi:10.3390/vaccines9040337 · Cited by 67
It takes two to tango: Dimerisation of glucocorticoid receptor and its anti-inflammatory functions
Nixon, M., Andrew, R., & Chapman, K. E. (2012) · Steroids · doi:10.1016/j.steroids.2012.09.013 · Cited by 62
Anuka, E., Gal, M., Stocco, D. M., & Orly, J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.003 · Cited by 60
Aldosterone rapidly represses protein kinase C activity in neonatal rat cardiomyocytes in vitro.
Sato, A., Liu, J.-P., & Funder, J. W. (1997) · Endocrinology · doi:10.1210/endo.138.8.5352 · Cited by 60
“Finally, in epithelial MR corticosterone and cortisol mimic the action of aldosterone, whereas in nonepithelial MR the physiologic glucocorticoids act, like spironolactone, as aldosterone antagonists (34); again, the basis for this difference is unclear.”
Adrenal and sex steroid receptor evolution: environmental implications.
Baker, M. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0260119 · Cited by 58
“By inactivating cortisol in the kidney, 11 -HSD-type 2 prevents unwanted occupancy of the MR by cortisol, which allows aldosterone to regulate mineralocorticoid responsive genes (Monder 1991, Edwards et al. 1996, Funder 1997).”
BackgroundMethodInfluentialNongenomic steroid actions: fact or fantasy?
Christ, M., Haseroth, K., Falkenstein, E., & Wehling, M. (1999) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60647-0 · Cited by 57
Lithium's role in neural plasticity and its implications for mood disorders
Gray, J. D., & McEwen, B. S. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12139 · Cited by 55
“eralocorticoid receptors (MRs) on neurons and glia to effect transcriptional regulation (11, 12).”
BackgroundSztechman, D., Czarzasta, K., Cudnoch-Jędrzejewska, A., Szczepańska-Sadowska, E., & Żera, T. (2018) · Journal of Physiology and Pharmacology · doi:10.26402/jpp.2018.6.01 · Cited by 55
Tokarz, J., Norton, W., Möller, G., de Angelis, M. H., & Adamski, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054851 · Cited by 56
“Additionally, in humans the affinity of cortisol for the mineralocorticoid receptor (MR) is comparable to that of aldosterone, the native MR ligand [24].”
Takeda, M., Tatsumi, T., Matsunaga, S., Hayashi, H., Kimata, M., Honsho, S., Nishikawa, S., Mano, A., Shiraishi, J., Yamada, H., et al. (2007) · Hypertension Research · doi:10.1291/hypres.30.427 · Cited by 52
Arvat, E., Maccagno, B., Giordano, R., Pellegrino, M., Broglio, F., Gianotti, L., Maccario, M., Camanni, F., & Ghigo, E. (2001) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.86.7.7663 · Cited by 55
Cooperativity and complementarity: Synergies in non-classical and classical glucocorticoid signaling
Samarasinghe, R. A., Witchell, S. F., & DeFranco, D. B. (2012) · Cell Cycle · doi:10.4161/cc.21018 · Cited by 54
El-mayet, F. S., Sawant, L., Thunuguntla, P., & Jones, C. (2017) · Journal of Virology · doi:10.1128/jvi.00904-17 · Cited by 50
Xu, B.-B., Strom, J., & Chen, Q. M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.019 · Cited by 52
“The receptor has α (94 kD) and β (90 kD) isoforms (Bamberger et al., 1996; Funder, 1997; Yudt and Cidlowski, 2002).”
BackgroundDiagram of the pathways of human steroidogenesis
Häggström, M., & Richfield, D. (2014) · doi:10.15347/wjm/2014.005 · Cited by 51
Transcriptional regulation of matrix metalloprotease gene expression in health and disease
Mancini, A. D. (2006) · Frontiers in bioscience · doi:10.2741/1809 · Cited by 46
“Glucocorticoids bind to their hormone-inducible nuclear receptors (GRs) and interact with or transactivate glucocorticoid response elements (GRE) present in the promoters of many genes (62).”
BackgroundCaudal, D., Jay, T., & Godsil, B. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00019 · Cited by 50
Rapid actions of aldosterone: lymphocytes, vascular smooth muscle and endothelial cells
Christ, M. (1999) · Steroids · doi:10.1016/s0039-128x(98)00103-2 · Cited by 51
Metadata
- Authors
- Funder, M.
- Affiliations
- Baker Medical Research Institute, Prahran, 3181 Australia
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 1997-02
- Volume
- 48
- Issue
- 1
- Pages
- 231-240
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2128569914
- Cited by
- 320
- References
- 0
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 3 · 2022: 2 · 2021: 13 · 2020: 6 · 2019: 10 · 2018: 8 · 2017: 13 · 2016: 17 · 2015: 13 · 2014: 21 · 2013: 16 · 2012: 18
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- glucocorticoid receptor, mineralocorticoid receptor, nuclear receptors, hormone response elements, transcriptional regulation, AP-1, NF-κB, protein-protein interaction, 11β-hydroxysteroid dehydrogenase, aldosterone, apparent mineralocorticoid excess, pseudohypoaldosteronism, epithelial sodium channel, cell surface receptors
- MeSH terms
- Aldosterone, Animals, DNA Mutational Analysis, Humans, Receptors, Glucocorticoid, Gene Expression, NF-kappa B, Receptors, Mineralocorticoid, Transcription Factor AP-1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review